OneOncology Unveils Data Demonstrating Increased Utilization of Genomic and Biomarker Testing at Community Cancer Centers

OneOncology Unveils Data Demonstrating Increased Utilization of Genomic and Biomarker Testing at Community Cancer Centers

OneOncology, the national platform for independent community oncology practices, and Genentech, a member of the Roche Group, presented data in two abstracts at the 2021 ASCO Quality Care Symposium examining genomic profiling and biomarker testing patterns in community oncology centers, as part of their multi-year strategic research partnership. The partnership demonstrates the enormous potential when oncology care provider networks and oncology therapy development firms collaborate working with real-world data. In this case, the result is Roche’s Flatiron Health’s OncoEMR® electronic health record.

Bringing Precision to the Community Practice

Bringing personalized cancer treatment to patients in community cancer centers requires biomarker and next generation sequencing (NGS) to identify actionable mutations and improve the time to targeted treatment. Thus, understanding testing patterns at different sites of care is an important component of increasing patient access to innovative targeted therapies for some advanced cancers.

"Biomarker and next generation sequencing are the backbone of personalized treatments in oncology," said Lee Schwartzberg, MD, Chief Medical Officer...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee